Key Financial Data Of Reporting Company

SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. - Filing #7303041

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-09-30
2023-04-01 to
2023-09-30
Key financial data of reporting company
Business results of reporting company
Net sales
12,508,481,000 JPY
26,450,468,000 JPY
11,884,047,000 JPY
Ordinary profit (loss)
1,829,136,000 JPY
7,015,923,000 JPY
3,756,455,000 JPY
Net assets
36,453,809,000 JPY
34,160,635,000 JPY
31,722,307,000 JPY
Total assets
88,983,563,000 JPY
76,302,347,000 JPY
68,558,336,000 JPY
Basic earnings (loss) per share
31.97
132.86
71.24
Diluted earnings per share
Equity-to-asset ratio
0.409 xbrli:pure
0.447 xbrli:pure
0.461 xbrli:pure
Net cash provided by (used in) operating activities
231,954,000 JPY
2,106,732,000 JPY
687,931,000 JPY
Net cash provided by (used in) investing activities
-7,522,061,000 JPY
-6,907,735,000 JPY
-3,671,934,000 JPY
Net cash provided by (used in) financing activities
7,658,424,000 JPY
5,318,656,000 JPY
2,124,234,000 JPY
Cash and cash equivalents
11,085,459,000 JPY
10,274,773,000 JPY
9,225,685,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.